NCT03750253

Brief Summary

Arthroscopic surgery is effective in treating osteochondral lesions of the talus. However, there are still some patients with postoperative ankle pain. This study aims to investigate the clinical efficacy of shock wave adjuvant therapy in the treatment of postoperative pain caused by cartilage injury of talus after arthroscopy and to provide basis for further popularization and application.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
5.7 years until next milestone

First Submitted

Initial submission to the registry

November 18, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 23, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

March 22, 2019

Status Verified

March 1, 2019

Enrollment Period

5.9 years

First QC Date

November 18, 2018

Last Update Submit

March 20, 2019

Conditions

Keywords

Extracorporeal Shock Wave TherapyOsteochondral Lesions of TalusArthroscopyPain-relief

Outcome Measures

Primary Outcomes (1)

  • Change of VAS scores before and after shock wave therapy

    The Visual Analogue Scale scores of the patients before and after the shock wave therapy are recorded. The scale ranges from 0-10 points, and decreases of the value represent a better outcome. The data analyses are performed with SPSS version 16.0 statistical software. Continuous variables are expressed as mean ± standard deviation, and 95% confidence intervals are determined. The data are compared by paired t test or rank-sum test. P value \< 0.05 is considered as statistically significant.

    6 weeks, 12 weeks and last follow-up at an average of 2 years after shock wave therapy

Secondary Outcomes (1)

  • Change of AOFAS scores before and after shock wave therapy

    6 weeks, 12 weeks and last follow-up last follow-up at an average of 2 years after shock wave therapy

Study Arms (1)

Extracorporeal Shock Wave Therapy

OTHER

Extracorporeal Shock Wave Therapy to relieve pain after arthroscopy for osteochondral lesions of talus

Other: Extracorporeal Shock Wave Therapy

Interventions

Extracorporeal Shock Wave Therapy will be used for pain-relief after arthroscopy for osteochondral lesions of the talus

Extracorporeal Shock Wave Therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For arthroscopy:
  • Ankle pain, aggravated after exercise or weight-bearing activity, accompanied by lameness, joint stiffness and dysfunction for at least 3 months
  • No talar collapse
  • Talar cartilage injury cases before stage Ⅳ of Hepple classification
  • For shock wave therapy:
  • Patients with micro-fractures treated with arthroscopic treatment of talar cartilage injury and were treated with routine rehabilitation training after arthroscopy
  • Patients who till complained obvious ankle pain 3 months after surgery

You may not qualify if:

  • Severe cardiovascular and cerebrovascular diseases
  • Hemorrhagic diseases, coagulation disorders
  • Bone immaturity
  • Thrombosis
  • Use of anti-immune agents
  • Various types of tumor patients
  • Pregnant women
  • History of mental illness
  • Patients who could not be followed
  • Patients with other lower extremity injuries after surgery and were unwilling to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southwest Hospital

Chongqing, China

Location

MeSH Terms

Interventions

Extracorporeal Shockwave Therapy

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Xiaojun Duan, M.D.

    Southwest Hospital, China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of the Center for Joint Surgery

Study Record Dates

First Submitted

November 18, 2018

First Posted

November 23, 2018

Study Start

March 1, 2013

Primary Completion

February 1, 2019

Study Completion

July 1, 2019

Last Updated

March 22, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations